Table 1.

Cancer incidence during the follow-up period after renal biopsy

	Nonspf	Amyl	CreGN	DMN	FSGS	IgAN	LN	MCD	MN	MPGN	TIN	TMA	Total
Total number of participants	28	3	19	51	82	366	25	69	111	32	31	5	822
Number of patients with incident cancer	1	1	2	4	5	12	3	1	11	2	3	0	45
Acute myelocytic leukemia	0	0	0	0	0	0	0	0	1	0	0	0	1
Acute myeloid leukemia	0	0	0	0	0	0	1	0	0	0	0	0	1
Bladder cancer	0	0	0	0	0	1	0	0	1	0	0	0	2
Breast cancer	0	0	0	0	0	1	0	0	0	0	0	0	1
Colon cancer	0	0	0	1	1	0	0	1	1	0	1	0	5
Hepatocellular carcinoma	0	0	0	3	0	1	0	0	1	1	0	0	6
Lung cancer	0	0	1	0	0	1	0	0	1	0	0	0	3
Lymphoma	0	0	0	0	0	0	1	0	1	0	1	0	3
Malignant brain tumor	0	0	0	0	1	0	0	0	0	0	0	0	1
Malignant neoplasm of retroperitoneum	0	0	0	0	0	0	0	0	0	0	1	0	1
Malignant neoplasm of soft tissue	0	0	0	0	1	0	0	0	0	0	0	0	1
Melanoma of rectum	0	0	0	0	0	1	0	0	0	0	0	0	1
Metastatic tumor to the spine	1	0	1	0	0	0	0	0	0	0	0	0	2
Multiple myeloma	0	1	0	0	0	0	0	0	1	0	0	0	2
Pancreatic cancer	0	0	0	0	0	0	0	0	0	0	0	0	0
Papillary thyroid carcinoma	0	0	0	0	0	4	0	0	0	0	0	0	4
Prostate cancer	0	0	0	0	1	1	0	0	1	0	0	0	3
Renal cell carcinoma	0	0	0	0	1	1	0	0	0	0	0	0	2
Squamous cell carcinoma of skin	0	0	0	0	0	0	0	0	2	0	0	0	2
Stomach cancer	0	0	0	0	0	1	0	0	1	1	0	0	3
Unspecified mass	0	0	0	0	0	0	1	0	0	0	0	0	1

Nonspf Nonspecific glomerulonephritis, Amyl Amyloidosis, CreGN Crescentic glomerulonephritis, DMN Diabetic nephropathy, FSGS Focal segmental glomerulonephritis, IgAN IgA nephropathy, LN Lupus nephritis, MCD Minimal change disease, MN Membranous nephropathy, MPGN Membranoproliferative glomerulonephritis, TIN Tubulointerstitial nephropathy, TMA Thrombotic microangiopathy